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Background: Patient satisfaction encompasses experiences of care quality and outcomes of 
treatment such as disability and perceived health state. Feedback should be used to develop services 
that correspond with patients' needs. Accurately capturing the different components that contribute 
to improved satisfaction levels is important and associated with better outcomes. 
Objectives: To investigate patients' experiences and satisfaction levels regarding inflammatory 
arthritis care and whether this impacts on disability and self reported global health states. 
Methods: 115 questionnaires were distributed randomly to patients with inflammatory arthritis who 
attended rheumatology outpatient clinics at University College Hospital, London between November 
2014 and January 2015. 104 were returned giving a response rate of 90%. Questions were semi-
structured using a Likert or visual analogue scale and focused on diagnosis, symptomatology, 
treatment history, health status and experiences of clinic attendance. 
Results: Rheumatoid arthritis accounted for 69% of inflammatory arthritis patients, 64% were 
female. Mean age in years was 50.44±17.98. 5.94% of patients had a disease duration of less than a 
year and 57% of patients had a duration greater than 10 years. Current treatment regime showed 
23% to be on DMARDs alone, 33% on biologics alone and 44% on combination therapy. Mean 
number of drugs tried before current drug regime was 3.06±2.13. 
72% of respondents assessed their current treatment regime as effective (Mean HAQ 1.28±0.82, 
Mean GVAS 39.44±29.44 (Global Visual Analogue Scale)). 31% of this perceived effective treatment 
group had a HAQ score <1 and 44% had a GVAS <30. 71% of respondents were satisfied with their 
current rheumatological health state (Mean HAQ 1.28±0.79, Mean GVAS 33.34±29.29). 30% of the 
satisfied group had a HAQ score <1 and 46% had a GVAS <30. Significant differences were found 
between patients who had high and low levels of rheumatological health satisfaction and perceived 
treatment efficacy as presented in the table. 
 
Conclusions: Overall health satisfaction and perceived treatment efficacy levels are high despite 
elevated perceived disease activity and disability scores. Predictors of health satisfaction have been 
shown to include patient involvement in decisions made regarding care, patients being listened to 
and being given appropriate emotional support. We have found that low perception of efficacy of 
treatment and low satisfaction levels are significantly associated with degree of morning stiffness, 
joint pain at night, low mood, disability and perception of not being listened to or involved in 
decision making. Interestingly those who had low perceived efficacy levels were significantly less 
likely to view themselves as having a disability secondary to their arthritis despite there not being a 
difference in HAQ disability index scores between the two groups. This may reflect differing levels of 
acceptability regarding the loss of function that can be associated with arthritis and the stigma that 
it brings. 
Physicians and patients often value different components of the outpatient clinic consultation. It is 
important to determine the factors that influence patients' satisfaction levels, and address them, 
especially when making management decisions. 
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